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Background: A hybrid approach to minimally invasive perventricular closure of VSD in infants is safe and effective,
and has been performed under guidance of transesophageal echocardiography (TEE). We applied transthoracic
echocardiographic (TTE) guidance to this hybrid approach, and compare results guided by TTE with those by TEE.
Methods: From January 2011 to January 2012, 71 infants with VSD were enrolled to undergo a minimally invasive
device closure. After evaluation of VSD by TTE, either TEE or TTE was used to guide the minimally invasive device
closure. 30 patients had TEE guidance, and 41 patients had TTE. All patients were followed for 3 months after the
operation.
Results: The TEE group had a success rate of 93.3% (28/30) for device implantation, compared with 92.7% (38/41)
in the TTE group. Two patients in the TEE group turned to surgical closure, one for involvement of the inlet area of
VSD demonstrated by TEE, another for moderate aortic regurgitation after device implantation. Two patients in the
TTE group also transferred to surgical closure, one for residual shunt, another for failure of the floppy wire across
the defect. In addition, one patient in the TTE group experienced dropout of the occluder one day postoperatively.
At 3-month follow-up, one patient had mild aortic regurgitation in the TEE group and in two patients in the TTE
group. There were no episodes of cardiac block, thromboembolism, or device displacement in either group.
Conclusions: TTE-guided VSD closure is feasible in infants, with results similar to those of TEE guidance, although
caution is advisable.
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Ventricular septal defect (VSD) is one of the most com-
mon forms of congenital heart disease, accounting for
approximately 20% of all congenital heart disease. A
large VSD may result in recurrent respiratory tract in-
fection, pulmonary hypertension, and early heart failure
in an infant. A left ventricle that is volume-overloaded
due to a large defect requires clinical intervention such
as surgical repair or device implantation. Percutaneous-* Correspondence: guicanzhang@yahoo.com
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reproduction in any medium, provided the ordevice closure is suitable in young children, but is im-
practical in infants due to limitations of the delivery sys-
tem. The hybrid approach such as minimally invasive
perventricular closure of the VSD, introduced by Amin and
coworkers in the late 1990 [1], has developed into a safe
and effective method [2-6], Previously, transesophageal
echocardiography (TEE) was thought to be necessary to
guide perventricular device closure [7,8], and sometimes
intracardiac echocardiography was used in this setting
[9]. Because transthoracic echocardiography (TTE) also
provides clear visualization of cardiac anatomy using
subcostal views in infants [10-12], we have used TTE asLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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device [13]. Nothing is known about the potential use of
TTE to guide device closure of a VSD in infants. The
purpose of this study is to investigate the feasibility of
TTE guidance of minimally invasive perventricular
device closure of a VSD in infants, and to compare
results guided by TTE with those by TEE.Methods
The present study was approved by the ethics committee
of our university and was conducted according to the te-
nets of the Declaration of Helsinki. Written informed
consent was obtained from the patients of their parents.Study patients
From January 2011 to January 2012, 71 infants (45 males
and 36 females) with perimembranous VSD were enrolled
in this study, and were intended to treat with perventricular
device closure with domestically made VSD occluders.
The patients ranged in age from 2 to 12 months (median,
7.8 months), and their weights ranged from 4 to 13 kg
(median, 8 kg). The study was approved by our institu-
tional review board, and written informed consent was
obtained from the parents of all patients. All patients were
routinely screened by clinical examination, chest X-rays,
electrocardiography, and TTE. Pre-operative TTE was
used mainly for selection of patients as candidates for im-
plantation of a perventricular device, and exclusion other
additional congenital lesions. Inclusion criteria for this
study were as follows: (1) perimembranous VSD, (2) dis-
tance of over 2 mm from the rim of the VSD to nearby
major cardiac structures such as the aortic, tricuspid, and
pulmonary valves, (3) no aortic regurgitation, (4) max-
imum VSD diameter ≤10 mm. Patients were divided into
the TEE group and the TTE group, according to the
method used to guide device implantation. TEE was
performed in 30 patients between January and July 2011,
and TTE was performed in 41 patients between August
2011 and January 2012.Figure 1 A TTE subcostal view showing the VSD. B The spectrum of DoEchocardiography
All patients were examined with a complete transthoracic
echocardiography using a Philip iE33 (Philip Medical
System, Andover, Massachusetts) or a Vivid 7 (GEVingmed
Ultrasound AS, Horten, Norway) imaging systems. Stand-
ard transthoracic imaging with color and Doppler interro-
gation from parasternal, apical, and subcostal views was
performed by ultrasonic specialists to examine carefully
the morphologic feature, size and rims of VSD. (Figure 1)
Either an infant transesophageal probe was placed in the
esophagus (TEE group), or a transthoracic probe placed
below the xiphoid (TTE group) was used to guide the de-
vice implantation. TEE mid-esophagus planes were mainly
used to reevaluate the VSD, and to guide the procedure in
TEE-group patients.
Device and implantation procedure
Two brands of domestically made VSD occluders were
used in this study: the Shanghai occluders (Shanghai
Shape Memory Alloy Ltd., CN, No.: 20103770832) and
Shenzhen occluders (Lifetech Scientific Ltd, CN,
No.: 20093770507) [14,15]. There were no much differ-
ence between these two brands of occluders, and the
occluders were selected according to surgeon’s prefer-
ence. Both occluders were made from an alloy of nickel
and titanium, and both have two kinds of occluder: a
symmetrical and an asymmetrical device (Figure 2). The
diameter of the VSD was measured at diastole phase,
and the occluder was selected based on this measure-
ment plus 2 mm. After incision of the lower sternum
(about 2 ~ 3 cm long), and exposure of right ventricle,
heparin (1 mg/kg) was administered, and the location of
puncture on the free wall of the right ventricle was de-
termined by pinning the right ventricle toward the defect
guided by echocardiography. A purse-string suture was
placed, and the right ventricular free wall was punctured
using a trocar. Then a floppy guide wire was inserted
and advanced through the VSD into the left ventricle,
and a 7Fr delivery sheath was advanced along the wire
into the left ventricle under echocardiographic guidanceppler imaging showing VSD.
Figure 2 The occluder device and delivery system.
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delivery cable and introduced into the delivery sheath,
and then advanced to the tip of the sheath. The left disc
of the occluder was deployed when the sheath was gen-
tly pulled back until the tip was in the left ventricle, then
the sheath were pulled back in the right ventricle and
the left disc was closed to the ventricular septum, and
the right disc of the occluder was deployed. Before re-
lease, the position of occluder disks and potential im-
pingement of the device on adjacent cardiac structures
were carefully evaluated, including assessment of residual
shunt, aortic regurgitation, and atrioventricular valve
function. After full evaluation, the occluder devices were
unscrewed to release (Figures 5, 6), and then the sheath
and delivery cable were withdrawn with the sutures tied
and trimmed.
After the operation, patients were transferred and ob-
served in an intensive care unit. A TTE examination
was performed before discharge to evaluate the effects
of implantation of the device. Each patient was evalu-
ated at 3 months after the procedure.Figure 3 A TEE four-chamber view showing the floppy guide wire ext
the VSD into the left ventricle, with the floppy guide wire withdrawn.Statistical analysis
All continuous variables were expressed as mean ± the
standard deviation or median with range as appropriate.
Clinical parameters between the 2 groups were compared
with the independent samples t test. Nominal variables
were compared between the 2 groups using Fisher’s exact
test. Aortic regurgitation was analyzed by the chi-square
test.Results
The perioperative biometric data as well as the hemo-
dynamic parameters are listed in Table 1. Occlusion was
successful in 28 of 30 patients (93.3%) in the TEE group,
and in 38 of 41 patients (92.7%) in the TTE group. Two
patients in the TEE group turned to surgical closure,
one for involvement inlet area of the VSD demonstrated
by TEE, and another for moderate aortic regurgitation
after device implantation. Two patients in the TTE
group also transferred to surgical closure, one for failure
of the floppy wire across the aneurysmal defect, and an-
other for residual shunt (velocity great than 300 cm/s). A
trivial, occluder inside residual shunt (velocity < 200 cm/s,
Figure 6) through the device was observed immediately
after the procedure in almost all patients in each group.
Minor complications were encountered in both groups,
including transient arrhythmia and occasional hypotension
in the course of device implantation. One patient in the
TEE group appeared to have transient hypoventilation ne-
cessitating temporary withdrawal of the TEE probe. One
patient in the TTE group experienced dropout of the
occluder one day postoperatively, and turned to open sur-
gery to find a malaligned defect in the perimembranous
area.
In comparison with the patients who underwent TEE-
guided closure with the device, patients who underwent
TTE-guided closure showed statistically similar results
in mean defect size (5.7 vs. 5.6 mm), mean device size
(7.5 vs. 7.5 mm), and procedure attempt success rate
(92.7% vs. 93.3%) (difference not statistically significant).ending through the defect. B The delivery cable extending through
Figure 4 A Color Doppler imaging of the TEE four-chamber view showing a VSD. B Occluder was deployed with left and right disc in
right position.
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operation time (33.8 vs. 41.1 minutes, P < 0.01).
The total follow-up period ranged from 1 to 6 months.
The occluders remained stable, and no obstruction was
observed in the left or right outflow tract. All trivial,
occluder inside residual shunt that were observed re-
solved, except for one patient in the TTE group, who
still had a mild residual shunt. Mild aortic regurgitation
was found in one patient in the TEE group, and in two
patients in the TTE group. There were no episodes of
cardiac block, thromboembolism, or device displacement
in either group.
Discussion
Our study demonstrated that TTE may be employed for
the assessment of VSD, selection of patients for device
closure, and guidance of perventricular device place-
ment in infants. Because of relatively clear definition of
VSD anatomy in infants, subcostal views are practically
useful in guiding the procedure of perventricular device
placement.
TEE is of course the best choice for all kinds of patients
in the situation of perventricular device placement be-
cause of the clear view of cardiac structures, which mark-
edly improves assessment of device position, proximity to
valve structures and residual flow. It is reported to be safeFigure 5 A TTE subcostal view showing the floppy guide wire extend
VSD into the left ventricle, with the floppy guide wire withdrawn.and feasible to perform transthoracic device closure of
VSDs without cardiopulmonary bypass [16-19]. TTE is
usually used as a tool of preparation by screening the
candidates for perventricular device placement, regard-
ing the resolution and image quality, TTE is inferior to
TEE, but TTE examination in infants under general
anesthesia usually have approving images, and TTE sub-
costal views is easy to manipulate and more welcoming by
surgeons, and may be used as a guiding tool in infants
with perimembranous VSD, and no patients in TTE group
need to place transesophageal probe additionally because
of imaging problem. Because relative deficiency of medical
resource and unbalanced development in developing
countries such as China, we believe that TTE-guidance
may act as an alternative choice in this circumstance.
When device placement is likely to be difficult, TEE-
guidance is indicated, and we would also emphasize that
TTE-guided VSD closure could only be carried out care-
fully by experienced hands.
Although morphologic variants of perimembranous
VSD are common, we choose this “suitable” type of
perimembranous VSD for device closure guided by TTE
alone, as we know this type of VSD was more easily to
apply device implantation. Here we would emphasize our
inclusion criteria of VSD closure, a size of about 3 to
8 mm of perimembranous VSD may be good candidateing through the defect. B The delivery cable extending through the
Figure 6 A TEE mid-esophageal left ventricular long axis plane showing a VSD. B An asymmetric VSD occluder was released with left and
right disc along the VSD in the right position.
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considered safe. In our experiences, deficiency of the
aortic rim is a risk factor for unsuccessful closure and a
significant predictor for residual leakage [15], A suffi-
cient aortic rim is crucial for safe and stable positioning
of the device and for prevention of impingement of the
aortic valves. When aortic regurgitation does occur, we
recommend using an asymmetrical device or transfer-
ring to open surgery, if new-onset mild above aortic
regurgitation and residual shunting exist after the device
placement, open surgery is the best choice and neces-
sary. When pulmonary hypertension occurs with a large
VSD, the ventricular septum may impinge towards left
ventricle, thus affecting the parallel line of ventricular
septum to the front wall of aorta, in such case may be
confused as malaligned VSD. And we had encountered
one event of dropout of occluder in TTE group and
open surgery confirmed a malaligned defect in the
perimembranous area. Careful echocardiographic evalu-
ation is needed to exclude the malaligned VSD [20-22]
because this special type of VSD is not amenable to
minimally perventricular device occlusion, and must be
treated with open surgery.Table 1 The preoperative biometric data as well as the
hemodynamic parameters of patients undergoing
intraoperative device closure of perimembraneous VSD
Group TEE Group TTE p value
Number of patients 30 41
Male/female 19/11 17/24 P > 0.05
Age (months) 8.13 ± 0.72 7.61 ± 0.59 P > 0.05
Body weight (kg) 8.13 ± 0.45 7.85 ± 0.39 P > 0.05
VSD size (mm) 5.72 ± 0.28 5.62 ± 0.17 P > 0.05
Occluder Size (mm) 7.51 ± 0.31 7.51 ± 0.17 P > 0.05
Qp/Qs 2.45 ± 0.04 2.44 ± 0.03 P > 0.05
operative time (minutes) 41.1 ± 1.2 33.8 ± 0.9 P < 0.05
aortic regurgitation (%) 1/30 2/41 P > 0.05
Follow-up (months) 3.2 ± 2.1 3.5 ± 2.2 P > 0.05Compared with TEE, TTE has several disadvantages
in guiding device closure of a VSD. First, because the
surgical field is at the lower sternum, it is somewhat
inconvenient for the ultrasonic specialist to hold the
probe in a fixed position. Fortunately, by tilting the
probe, it is easy to clearly show most of the main struc-
tures of the right and left inflow/outflow tracts.
Secondly, the problem of contamination must be em-
phasized because of subcostal windows adjacent to the
surgical field, therefore, we used a sterile sheath to
cover the probe, and probe was placed subcostally at
least 5 cm away from the surgical field. When TEE is
used in infants, we have some concern about gastro-
esophageal injury and respiratory compression [23].
Using TTE guidance sometimes can eliminate such
complications, and it is quite satisfactory to apply echo
guidance with TTE in infants even less than 5 Kg.
Some technical considerations of perventricular VSD
device closure should also be addressed. First, passing the
guide-wire and the delivery sheath across the defect is a
crucial step for successful closure. The echo reflection of
the guide-wire and delivery sheath is easy to find. When
passing the delivery sheath along the guide-wire, caution
should be exercised in examining the tip of the delivery
sheath going through the defect, at this moment right red
blood may arise from the other end of the delivery sheath,
this observation can also help to identify the tip of delivery
sheath into the left ventricle. The surgeons and ultrasonic
specialists should always be cautious not to damage car-
diac structures such as the aortic or mitral valves during
the procedure. Second, TEE used in the early stages of the
study provided a lot of experiences, and in later stages of
the study TEE probe had problem, we applied only TTE
to guide VSD closure in the TTE group. Our results show
that the TTE group had a reduced procedure time com-
pared with the TEE group. Because TTE subcostal views
are reliable in detection and evaluation of VSD in infants,
we hope that performing the VSD closure under TTE
guidance could reduce procedure time and also provide
increased patient comfort.
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spective registry. In addition, the decision as to which
VSD closure would be most appropriate in each case
was made at the discretion of the ultrasonic specialist,
the surgeon, and the patient’s parents. The study was
conducted in only one institution, and the sample of
study was not large. A longer follow-up period is also
needed to evaluate the results.
Conclusion
Our study shows that TTE can also be used to as an alter-
native to guide the VSD device implantation, with caution
and in experienced hands, it may be safe and feasible to
perform TTE-guided VSD closure in infants.
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